OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
New Methods and Technologies for Measuring Uremic Toxins and Quantifying Dialysis Adequacy
Raymond Vanholder, Jente Boelaert, Griet Glorieux, et al.
Seminars in Dialysis (2014) Vol. 28, Iss. 2, pp. 114-124
Open Access | Times Cited: 25
Raymond Vanholder, Jente Boelaert, Griet Glorieux, et al.
Seminars in Dialysis (2014) Vol. 28, Iss. 2, pp. 114-124
Open Access | Times Cited: 25
Showing 25 citing articles:
Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target
Ali Ramezani, Ziad A. Massy, Björn Meijers, et al.
American Journal of Kidney Diseases (2015) Vol. 67, Iss. 3, pp. 483-498
Open Access | Times Cited: 339
Ali Ramezani, Ziad A. Massy, Björn Meijers, et al.
American Journal of Kidney Diseases (2015) Vol. 67, Iss. 3, pp. 483-498
Open Access | Times Cited: 339
Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update
Raymond Vanholder, Anneleen Pletinck, Eva Schepers, et al.
Toxins (2018) Vol. 10, Iss. 1, pp. 33-33
Open Access | Times Cited: 283
Raymond Vanholder, Anneleen Pletinck, Eva Schepers, et al.
Toxins (2018) Vol. 10, Iss. 1, pp. 33-33
Open Access | Times Cited: 283
Classification of Uremic Toxins and Their Role in Kidney Failure
Mitchell H. Rosner, Thiago Reis, Faeq Husain‐Syed, et al.
Clinical Journal of the American Society of Nephrology (2021) Vol. 16, Iss. 12, pp. 1918-1928
Open Access | Times Cited: 158
Mitchell H. Rosner, Thiago Reis, Faeq Husain‐Syed, et al.
Clinical Journal of the American Society of Nephrology (2021) Vol. 16, Iss. 12, pp. 1918-1928
Open Access | Times Cited: 158
The Role of the Gut Microbiome on Chronic Kidney Disease
Benedita Sampaio‐Maia, Liliana Simões‐Silva, Manuel Pestana, et al.
Advances in applied microbiology (2016), pp. 65-94
Closed Access | Times Cited: 103
Benedita Sampaio‐Maia, Liliana Simões‐Silva, Manuel Pestana, et al.
Advances in applied microbiology (2016), pp. 65-94
Closed Access | Times Cited: 103
Mechanism of Prominent Trimethylamine Oxide (TMAO) Accumulation in Hemodialysis Patients
Xin Hai, Veeda Landeras, Mirela Dobre, et al.
PLoS ONE (2015) Vol. 10, Iss. 12, pp. e0143731-e0143731
Open Access | Times Cited: 100
Xin Hai, Veeda Landeras, Mirela Dobre, et al.
PLoS ONE (2015) Vol. 10, Iss. 12, pp. e0143731-e0143731
Open Access | Times Cited: 100
Modulation of the Gut Microbiota by Resistant Starch as a Treatment of Chronic Kidney Diseases: Evidence of Efficacy and Mechanistic Insights
Matthew Snelson, Nicole J. Kellow, Melinda T. Coughlan
Advances in Nutrition (2018) Vol. 10, Iss. 2, pp. 303-320
Open Access | Times Cited: 75
Matthew Snelson, Nicole J. Kellow, Melinda T. Coughlan
Advances in Nutrition (2018) Vol. 10, Iss. 2, pp. 303-320
Open Access | Times Cited: 75
End-stage renal disease is different from chronic kidney disease in upregulating ROS-modulated proinflammatory secretome in PBMCs - A novel multiple-hit model for disease progression
Ruijing Zhang, Jason Saredy, Ying Shao, et al.
Redox Biology (2020) Vol. 34, pp. 101460-101460
Open Access | Times Cited: 51
Ruijing Zhang, Jason Saredy, Ying Shao, et al.
Redox Biology (2020) Vol. 34, pp. 101460-101460
Open Access | Times Cited: 51
Short-term Effects of Acute Kidney Injury
Kai Singbartl, Michael Joannidis
Critical Care Clinics (2015) Vol. 31, Iss. 4, pp. 751-762
Closed Access | Times Cited: 60
Kai Singbartl, Michael Joannidis
Critical Care Clinics (2015) Vol. 31, Iss. 4, pp. 751-762
Closed Access | Times Cited: 60
A haemocompatible and scalable nanoporous adsorbent monolith synthesised using a novel lignin binder route to augment the adsorption of poorly removed uraemic toxins in haemodialysis
Susan Sandeman, Yishan Zheng, Ganesh Ingavle, et al.
Biomedical Materials (2017) Vol. 12, Iss. 3, pp. 035001-035001
Open Access | Times Cited: 33
Susan Sandeman, Yishan Zheng, Ganesh Ingavle, et al.
Biomedical Materials (2017) Vol. 12, Iss. 3, pp. 035001-035001
Open Access | Times Cited: 33
Targeted Metabolomic Profiling of Peritoneal Dialysis Effluents Shows Anti-oxidative Capacity of Alanyl-Glutamine
Florian Wiesenhofer, Rebecca Herzog, Michael Böehm, et al.
Frontiers in Physiology (2019) Vol. 9
Open Access | Times Cited: 22
Florian Wiesenhofer, Rebecca Herzog, Michael Böehm, et al.
Frontiers in Physiology (2019) Vol. 9
Open Access | Times Cited: 22
Proteomic Investigations into Hemodialysis Therapy
Mario Bonomini, Vittorio Sirolli, Luisa Pieroni, et al.
International Journal of Molecular Sciences (2015) Vol. 16, Iss. 12, pp. 29508-29521
Open Access | Times Cited: 21
Mario Bonomini, Vittorio Sirolli, Luisa Pieroni, et al.
International Journal of Molecular Sciences (2015) Vol. 16, Iss. 12, pp. 29508-29521
Open Access | Times Cited: 21
Examining hemodialyzer membrane performance using proteomic technologies
Mario Bonomini, Luisa Pieroni, Lorenzo Di Liberato, et al.
Therapeutics and Clinical Risk Management (2017) Vol. Volume 14, pp. 1-9
Open Access | Times Cited: 19
Mario Bonomini, Luisa Pieroni, Lorenzo Di Liberato, et al.
Therapeutics and Clinical Risk Management (2017) Vol. Volume 14, pp. 1-9
Open Access | Times Cited: 19
Reporting of “dialysis adequacy” as an outcome in randomised trials conducted in adults on haemodialysis
Sanne Steyaert, Els Holvoet, Evi Nagler, et al.
PLoS ONE (2019) Vol. 14, Iss. 2, pp. e0207045-e0207045
Open Access | Times Cited: 19
Sanne Steyaert, Els Holvoet, Evi Nagler, et al.
PLoS ONE (2019) Vol. 14, Iss. 2, pp. e0207045-e0207045
Open Access | Times Cited: 19
Is Fluorescence Valid to Monitor Removal of Protein Bound Uremic Solutes in Dialysis?
Jürgen Arund, Merike Luman, Fredrik Uhlin, et al.
PLoS ONE (2016) Vol. 11, Iss. 5, pp. e0156541-e0156541
Open Access | Times Cited: 17
Jürgen Arund, Merike Luman, Fredrik Uhlin, et al.
PLoS ONE (2016) Vol. 11, Iss. 5, pp. e0156541-e0156541
Open Access | Times Cited: 17
Proteomic Characterization of a New asymmetric Cellulose Triacetate Membrane for Hemodialysis
Maurizio Ronci, Lidia Leporini, Paolo Felaco, et al.
PROTEOMICS - CLINICAL APPLICATIONS (2018) Vol. 12, Iss. 6
Closed Access | Times Cited: 12
Maurizio Ronci, Lidia Leporini, Paolo Felaco, et al.
PROTEOMICS - CLINICAL APPLICATIONS (2018) Vol. 12, Iss. 6
Closed Access | Times Cited: 12
The membrane perspective of uraemic toxins: which ones should, or can, be removed?
Sudhir K. Bowry, Peter Kotanko, Rainer Himmele, et al.
Clinical Kidney Journal (2021) Vol. 14, Iss. Supplement_4, pp. i17-i31
Open Access | Times Cited: 9
Sudhir K. Bowry, Peter Kotanko, Rainer Himmele, et al.
Clinical Kidney Journal (2021) Vol. 14, Iss. Supplement_4, pp. i17-i31
Open Access | Times Cited: 9
Personalized Approach and Precision Medicine in Supportive and End-of-Life Care for Patients With Advanced and End-Stage Kidney Disease
Sara N. Davison
Seminars in Nephrology (2018) Vol. 38, Iss. 4, pp. 336-345
Closed Access | Times Cited: 7
Sara N. Davison
Seminars in Nephrology (2018) Vol. 38, Iss. 4, pp. 336-345
Closed Access | Times Cited: 7
Impact of Metabolomics Technologies on the Assessment of Peritoneal Membrane Profiles in Peritoneal Dialysis Patients: A Systematic Review
Antonia Kondou, Olga Begou, John Dotis, et al.
Metabolites (2022) Vol. 12, Iss. 2, pp. 145-145
Open Access | Times Cited: 4
Antonia Kondou, Olga Begou, John Dotis, et al.
Metabolites (2022) Vol. 12, Iss. 2, pp. 145-145
Open Access | Times Cited: 4
Uremic Toxicity
Raymond Vanholder, Griet Glorieux
Elsevier eBooks (2022), pp. 16-44
Closed Access | Times Cited: 4
Raymond Vanholder, Griet Glorieux
Elsevier eBooks (2022), pp. 16-44
Closed Access | Times Cited: 4
Comparison of 2 medium cutoff dialyzers versus on‐line hemodiafiltration regarding depurative ability and albumin loss: An uncontrolled clinical research
Patricia Martínez‐Miguel, Rocío Gimena Muñoz, Marta Barrionuevo González, et al.
Artificial Organs (2022) Vol. 47, Iss. 3, pp. 589-594
Closed Access | Times Cited: 4
Patricia Martínez‐Miguel, Rocío Gimena Muñoz, Marta Barrionuevo González, et al.
Artificial Organs (2022) Vol. 47, Iss. 3, pp. 589-594
Closed Access | Times Cited: 4
Uremic toxins: an integrated overview of classification and pathobiology
Richard J. Glassock, Shaul G. Massry
Elsevier eBooks (2021), pp. 77-89
Closed Access | Times Cited: 5
Richard J. Glassock, Shaul G. Massry
Elsevier eBooks (2021), pp. 77-89
Closed Access | Times Cited: 5
Specific Pathways to Prevent Early Vascular Aging
Tine De Backer, Pierre Boutouyrie, Luc Van Bortel
Elsevier eBooks (2024), pp. 545-560
Closed Access
Tine De Backer, Pierre Boutouyrie, Luc Van Bortel
Elsevier eBooks (2024), pp. 545-560
Closed Access
Blood Cell Proteomics in Chronic Kidney Disease
Mario Bonomini, Luisa Pieroni, Maurizio Ronci, et al.
The Open Urology & Nephrology Journal (2018) Vol. 11, Iss. 1, pp. 28-38
Open Access | Times Cited: 2
Mario Bonomini, Luisa Pieroni, Maurizio Ronci, et al.
The Open Urology & Nephrology Journal (2018) Vol. 11, Iss. 1, pp. 28-38
Open Access | Times Cited: 2
Reporting of “dialysis adequacy” as an outcome in randomised trials conducted in adults on haemodialysis: a systematic review
Sanne Steyaert, Els Holvoet, Evi Nagler, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2018)
Open Access
Sanne Steyaert, Els Holvoet, Evi Nagler, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2018)
Open Access
Gene Expression Profile of HCAEC Cells Exposed to Serum From Chronic Kidney Disease Patients: Role of MAPK Signaling Pathway
Angélica Rangel-López, Oscar Alberto Pérez-González, Sergio Juárez‐Méndez, et al.
Research Square (Research Square) (2021)
Open Access
Angélica Rangel-López, Oscar Alberto Pérez-González, Sergio Juárez‐Méndez, et al.
Research Square (Research Square) (2021)
Open Access
